| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/CLPT.2012.220 |
| P698 | PubMed publication ID | 23337525 |
| P2093 | author name string | J Woodcock | |
| M Wosinska | |||
| P2860 | cites work | The reality of drug shortages--the case of the injectable agent propofol | Q43016715 |
| P433 | issue | 2 | |
| P921 | main subject | drug shortage | Q94443615 |
| P304 | page(s) | 170-176 | |
| P577 | publication date | 2012-11-07 | |
| P1433 | published in | Clinical Pharmacology & Therapeutics | Q1101529 |
| P1476 | title | Economic and technological drivers of generic sterile injectable drug shortages | |
| P478 | volume | 93 |
| Q93588067 | Q93588067 |
| Q28547012 | A Qualitative Approach to a Better Understanding of the Problems Underlying Drug Shortages, as Viewed from Belgian, French and the European Union's Perspectives |
| Q58699813 | A challenge for healthcare but just another opportunity for illegitimate online sellers: Dubious market of shortage oncology drugs |
| Q94955085 | ACMT Position Statement: Medication Shortages During Coronavirus Disease Pandemic |
| Q37125056 | Association Between the Number of Suppliers for Critical Antineoplastics and Drug Shortages: Implications for Future Drug Shortages and Treatment. |
| Q35000438 | Biosimilars 101: considerations for U.S. oncologists in clinical practice |
| Q28307153 | Chemotherapy drug shortages in pediatric oncology: a consensus statement |
| Q28552955 | Current Situation, Determinants, and Solutions to Drug Shortages in Shaanxi Province, China: A Qualitative Study |
| Q91977733 | Current perspectives on biosimilars |
| Q40771220 | Despite Federal Legislation, Shortages Of Drugs Used In Acute Care Settings Remain Persistent And Prolonged. |
| Q38695093 | Drug Industry Groups Oppose FDA "Quality Metrics" Plan: The Agency Wants to Use Manufacturing Data to Attack Drug Shortages |
| Q34677617 | Drug shortages in European countries: a trade-off between market attractiveness and cost containment? |
| Q37733889 | Drug shortages in Israel: regulatory perspectives, challenges and solutions |
| Q37358349 | Empty shelves, full of frustration: consequences of drug shortages and the need for action |
| Q34612781 | Formulary Selection Criteria for Biosimilars: Considerations for US Health-System Pharmacists |
| Q93338405 | Generic Drugs in the United States: Policies to Address Pricing and Competition |
| Q59329850 | Generic prescription drug price increases: which products will be affected by proposed anti-gouging legislation? |
| Q91438559 | Impact of Oncology Drug Shortages on Chemotherapy Treatment |
| Q92524797 | Implications of the Parenteral Opioid Shortage for Prescription Patterns and Pain Control Among Hospitalized Patients With Cancer Referred to Palliative Care |
| Q38621600 | Influencers of generic drug utilization: A systematic review |
| Q28544114 | Insights into European drug shortages: a survey of hospital pharmacists |
| Q37681429 | Medicine shortages: Implications for the Australian healthcare system. |
| Q33732967 | Medicines shortages-unpicking the evidence from a year in South Africa |
| Q96292931 | The Drug Shortage Era: A Scoping Review of the Literature 2001-2019 |
| Q90089596 | The French reporting system for drug shortages: description and trends from 2012 to 2018: an observational retrospective study |
| Q39259740 | The Impact of Shortages on Medication Prices: Implications for Shortage Prevention |
| Q95843707 | The Landscape of Prescription Drug Shortages During the COVID-19 Pandemic |
| Q57291977 | The current status and effects of emergency drug shortages in China: Perceptions of emergency department physicians |
| Q36347871 | The impact of chemotherapy shortages on COG and local clinical trials: a report from the Children's Oncology Group |
| Q50115805 | The process defines the product: what really matters in biosimilar design and production? |
| Q36325432 | Time spent by Belgian hospital pharmacists on supply disruptions and drug shortages: An exploratory study |
| Q36226420 | Toward a European definition for a drug shortage: a qualitative study |
| Q37381759 | Why drug shortages are an ethical issue |
Search more.